ProfileGDS4132 / 231435_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 16% 17% 16% 15% 16% 20% 18% 19% 19% 16% 19% 20% 16% 19% 24% 23% 22% 21% 19% 19% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 10134.610916
GSM201543Muscle PCOS pioglitazone 12130.882717
GSM201544Muscle PCOS pioglitazone 16135.614316
GSM201545Muscle PCOS pioglitazone 20133.491915
GSM201829Muscle PCOS pioglitazone 23134.45116
GSM201830Muscle PCOS pioglitazon 25145.532120
GSM201831Muscle PCOS pioglitazone 27134.425218
GSM201832Muscle PCOS pioglitazone 3142.769719
GSM201833Muscle PCOS pioglitazone 4138.134319
GSM201834Muscle PCOS pioglitazone 8130.642916
GSM201835Muscle PCOS after pioglitazone 10232.041619
GSM201836Muscle PCOS after pioglitazone 12235.868520
GSM201837Muscle PCOS after pioglitazone 16226.310716
GSM201838Muscle PCOS after pioglitazone 20237.200919
GSM201839Muscle PCOS after pioglitazone 23250.618624
GSM201840Muscle PCOS after pioglitazone 25251.049923
GSM201841Muscle PCOS after pioglitazone 27237.908722
GSM201842Muscle PCOS after pioglitazone 3237.44721
GSM201843Muscle PCOS after pioglitazone 4242.807819
GSM201844Muscle PCOS after pioglitazone 8236.744619